EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 7

HMB (beta-hydroxy-beta-methylbutyrate)

Also called: beta-hydroxy-beta-methylbutyrate, β-hydroxy-β-methylbutyrate, calcium HMB, HMB free acid

HMB is a metabolite of the branched-chain amino acid leucine; about 5% of the body's leucine is converted into HMB. Supplements contain a calcium salt or a calcium-free free-acid form.

Category
Other
Forms
HMB monohydrated calcium salt (HMB-Ca) or calcium-free HMB free acid (HMB-FA)
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2020 meta-analysis analyzed 11 double-blind RCTs (302 adults aged 18–45) of 3 g/day HMB versus placebo during resistance training; in 4 of them HMB was added to a protein or other supplement that the placebo group also took. [4]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what HMB (beta-hydroxy-beta-methylbutyrate) does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for HMB (beta-hydroxy-beta-methylbutyrate), evidence grade and finding
Topic studiedGradeWhat the evidence shows
Fat-free (lean) mass in older adultsBA 2021 meta-analysis of 9 RCTs (448 older adults) found higher fat-free mass with HMB than control and no effect on fat mass; HMB combined with exercise showed no additional fat-free mass change. [2]
Muscle mass and strength in clinical conditions with muscle lossBA 2019 meta-analysis of 15 RCTs (2,137 patients) of HMB alone or HMB-containing supplements found small increases in muscle mass and strength; no study had low risk of bias in all categories. [3]
Body composition and strength gains during resistance training in young adultsXA 2020 meta-analysis (11 studies analyzed; 302 participants aged 18–45) found a small effect on total body mass but no significant effect on fat-free mass, fat mass or strength. [4]
Recovery from exerciseBODS reports general agreement that HMB helps speed recovery from exercise intense enough to damage skeletal muscle, but summarizes numerous clinical trials as having conflicting results; there is no expert consensus on taking it for months. [1]

Main constituents: Beta-hydroxy-beta-methylbutyrate (HMB), a leucine metabolite [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Studies used 1.5 to 6 g/day (most commonly 3 g) for 1 day to 6 weeks; ODS notes evidence that 3 g provides results equivalent to 6 g and better than 1.5 g. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    1 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • ODS states users tolerate HMB well and it is safe at daily intakes of 3 g for 3 to 8 weeks; its safety and efficacy have not been studied in adolescents, and there is no expert consensus on its safety over several months or longer. [1]
  • HMB-Ca is approximately 13% calcium by weight; 3 g/day adds about 400 mg calcium to the diet. [1]
Quality

Identity, quality and standardization

  • A 2011 crossover study (two studies of 8 adults each, 1 g HMB) found HMB free acid gel gave faster and higher plasma peaks (about 38 vs 128 min; 249 vs 131 µmol/L) than calcium HMB capsules. [5]
  • A 2024 crossover study (16 young adults, 1 g HMB) found lower plasma exposure with free-acid capsules than calcium HMB capsules (relative bioavailability 61.5% vs 104.8%, versus calcium HMB in water); the 2011 study had used a free-acid gel. [6]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Beta-hydroxy-beta-methylbutyrate (HMB), a metabolite of leucine; sold as the mono-hydrated calcium salt (HMB-Ca, about 13% calcium by weight) or the free acid (HMB-FA) Organic acids (hydroxy acid; leucine metabolite) [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 1 entry naming HMB, an HMB–L-arginine ingredient (NDI 230 submitted 2003-05-05). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of HMB (beta-hydroxy-beta-methylbutyrate) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no study of HMB (checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • In two crossover studies (4 men and 4 women each) given 1 g HMB, time to peak plasma HMB was 128 min for calcium HMB capsules versus 38 min for free acid gel; peaks were 131 versus 249 µmol/L and half-lives 3.17 versus 2.50 h. [P6]
  • In a 2024 crossover study of 16 young adults given 1 g HMB, free-acid capsules gave lower AUC and Cmax than calcium HMB (relative bioavailability 61.5% vs 104.8% for calcium HMB capsules, with calcium HMB in water as reference); half-life was similar across forms. [P7]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
  6. Fuller JC Jr, et al. Free acid gel form of β-hydroxy-β-methylbutyrate (HMB) improves HMB clearance from plasma in human subjects compared with the calcium HMB salt. Br J Nutr 2011;105(3):367-372 (PMID 21134325), 2011-02. pubmed.ncbi.nlm.nih.gov
  7. Ribeiro HR, et al. Superior bioavailability of the calcium salt form of β-hydroxy-β-methylbutyrate compared with the free acid form. Amino Acids 2024;56(1):27 (PMID 38564019), 2024-04-02. pubmed.ncbi.nlm.nih.gov
Sources

Sources

  1. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date captured; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
  2. Lin Z, et al. Effects of oral administration of β-hydroxy β-methylbutyrate on lean body mass in older adults: a systematic review and meta-analysis. Eur Geriatr Med 2021;12(2):239-251 (PMID 33034021), 2021-04. pubmed.ncbi.nlm.nih.gov
  3. Bear DE, et al. β-Hydroxy-β-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysis. Am J Clin Nutr 2019;109(4):1119-1132 (PMID 30982854), 2019-04-01. pubmed.ncbi.nlm.nih.gov
  4. Jakubowski JS, et al. Supplementation with the leucine metabolite β-hydroxy-β-methylbutyrate (HMB) does not improve resistance exercise-induced changes in body composition or strength in young subjects: a systematic review and meta-analysis. Nutrients 2020;12(5):1523 (PMID 32456217), 2020-05-23. pubmed.ncbi.nlm.nih.gov
  5. Fuller JC Jr, et al. Free acid gel form of β-hydroxy-β-methylbutyrate (HMB) improves HMB clearance from plasma in human subjects compared with the calcium HMB salt. Br J Nutr 2011;105(3):367-372 (PMID 21134325), 2011-02. pubmed.ncbi.nlm.nih.gov
  6. Ribeiro HR, et al. Superior bioavailability of the calcium salt form of β-hydroxy-β-methylbutyrate compared with the free acid form. Amino Acids 2024;56(1):27 (PMID 38564019), 2024-04-02. pubmed.ncbi.nlm.nih.gov
  7. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.